Though recombinant factor VIIa didn’t improve outcomes overall, treating very early and in those with a spot sign on CT may ...

Neither stenting nor endarterectomy provided a boost versus medical therapy alone in patients with asymptomatic stenosis.

The mechanism remains unclear, but GLP-1 users had less MACE, CV death, and all-cause death driven by fewer amputations.

A bundle of protocols including patient education, skin prep, and glove changes reduced infections at a large US surgical ...

Overcoming clinical inertia around starting and intensifying antihypertensive drugs is key, a researcher says.

Sripal Bangalore and C. Michael Gibson discuss whether ticagrelor is noninferior to prasugrel in patients with diabetes and ...

Transparency is needed to improve equity, though it can be awkward to talk about salary, says Thomas MacGillivray.

Observational data point to the scope of opportunity that lies in GLP-1 drugs, SGLT2 inhibitors, and nonsteroidal MRAs.

Topics spanned from GLP-1s to aorto-coronary bypass without surgery, Lp(a)’s extended reach, US dietary guidelines, and more.

This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...

The study supports “more is more” when it comes to arterial conduits until additional RCT data arrive, researcher says.

The agency says there have been 22 injuries and no deaths associated with this potentially high-risk device issue.